{"database": "openregs", "table": "documents", "rows": [["FDA-2020-D-2214-0001", "FDA", "FDA-2020-D-2214", "Dry Eye: Developing Drugs for Treatment; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2020-12-17T05:00:00Z", 2020, 12, "2020-12-17T05:00:00Z", "2021-03-18T03:59:59Z", "2022-09-12T19:47:56Z", "2020-27762", 0, 0, "09000064849a4491"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2020-D-2214-0001"], "units": {}, "query_ms": 0.3546950174495578, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}